- Report
- December 2024
- 31 Pages
Germany
From €4434EUR$4,995USD£3,843GBP
- Report
- November 2024
- 750 Pages
Global
From €1775EUR$2,000USD£1,539GBP
- Report
- November 2024
- 750 Pages
Global
From €1775EUR$2,000USD£1,539GBP
- Report
- October 2024
- 216 Pages
Global
From €3551EUR$4,000USD£3,077GBP
- Report
- September 2024
- 117 Pages
Global
From €3995EUR$4,500USD£3,462GBP
- Report
- May 2024
- 142 Pages
Global
From €3551EUR$4,000USD£3,077GBP
- Report
- January 2024
- 315 Pages
Global
From €3107EUR$3,500USD£2,693GBP
- Report
- January 2024
- 120 Pages
United States
€3107EUR$3,500USD£2,693GBP
- Report
- November 2023
- 190 Pages
Global
From €4394EUR$4,950USD£3,808GBP
- Report
- November 2023
- 110 Pages
Global
From €2619EUR$2,950USD£2,270GBP
- Report
- November 2023
- 109 Pages
Africa, Middle East
From €2619EUR$2,950USD£2,270GBP
- Report
- November 2023
- 119 Pages
Asia Pacific
From €3063EUR$3,450USD£2,654GBP
- Report
- November 2023
- 122 Pages
Europe
From €3063EUR$3,450USD£2,654GBP
- Report
- November 2023
- 107 Pages
From €2619EUR$2,950USD£2,270GBP
- Report
- November 2023
- 119 Pages
North America
From €2619EUR$2,950USD£2,270GBP
- Report
- November 2023
- 130 Pages
Global
From €1731EUR$1,950USD£1,500GBP
- Report
- June 2023
- 270 Pages
Global
From €2131EUR$2,400USD£1,846GBP
- Report
- March 2023
- 26 Pages
Global
€10875EUR$12,250USD£9,425GBP
- Drug Pipelines
- December 2022
- 148 Pages
Global
From €13311EUR$14,995USD£11,537GBP
- Report
- October 2021
- 180 Pages
United States
From €2219EUR$2,500USD£1,923GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more